Acurx Pharmaceuticals, Inc. (ACXP) vs Intelligent Bio Solutions Inc. (INBS)
A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Intelligent Bio Solutions Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACXP
Acurx Pharmaceuticals, Inc.
$1.32HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
INBS
Intelligent Bio Solutions Inc.
$1.62HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — ACXP vs INBS
growth of $100 · dividends reinvested · last 5yACXP -99.2% (-61.6%/yr)INBS -100.0% (-82.2%/yr)ACXP compounded faster over this window
Log scale — wide-divergence pair
ACXP INBS
ACXP vs INBS: by the numbers
- •ACXP is the larger company ($6M vs $5M market cap).
- •Both run net losses; ACXP's is the smaller (0.00% vs -294.91% net margin).
Metrics side by side
Valuation
| Metric | ACXP | INBS |
|---|---|---|
| P/S ratio | N/A | 1.27 |
| P/B ratio | 0.70 | 0.98 |
Profitability
| Metric | ACXP | INBS |
|---|---|---|
| Gross margin | 0.00% | 48.63% |
| Operating margin | 0.00% | -305.03% |
| Net margin | 0.00% | -294.91% |
| ROE | -92.08% | -225.57% |
| ROIC | -94.08% | -179.58% |
Growth (annualized)
| Metric | ACXP | INBS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 19.95% |
| Total return CAGR (5Y) | -57.41% | -80.26% |
Frequently asked
- How have ACXP and INBS total returns compared?
- Over the past 5 years, ACXP delivered -57.41% and INBS delivered -80.26% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Acurx Pharmaceuticals ROEIntelligent Bio Solutions ROEAcurx Pharmaceuticals operating marginIntelligent Bio Solutions operating marginAcurx Pharmaceuticals revenue growthIntelligent Bio Solutions revenue growthAcurx Pharmaceuticals free cash flowIntelligent Bio Solutions free cash flow
Acurx Pharmaceuticals & Intelligent Bio Solutions appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.